RLMD
NASDAQ · Pharmaceuticals
Relmada Therapeutics Inc
$6.84
-0.05 (-0.73%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+446.3% upside
Low Target
$22.23
Average Target
$37.37
High Target
$43.38
Current Price
$6.84
Current
$6.84
$6.84
Target
$37.37
$37.37
$22.23
$37.37 avg
$43.38
Scenario Analysis
Bear Case
$22.23
225.0%
Low target
Base Case
$37.37
+446.3%
Avg target
Bull Case
$43.38
+534.2%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$8.00
-14.5% from high
52-Week Low
$0.52
+1,215.4% from low
Target vs 52W High
$37.37
+367.1% vs high
Peer Consensus — Pharmaceuticals